Edwards Lifesciences (Mexico) Today

EW Stock  MXN 1,415  9.00  0.64%   

Performance

1 of 100

 
Weak
 
Strong
Weak

Odds Of Distress

Less than 9

 
High
 
Low
Low
Edwards Lifesciences is trading at 1415.00 as of the 12th of December 2024; that is 0.64% increase since the beginning of the trading day. The stock's open price was 1406.0. Edwards Lifesciences has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. The performance scores are derived for the period starting the 12th of November 2024 and ending today, the 12th of December 2024. Click here to learn more.
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California. The company has 618.26 M outstanding shares. More on Edwards Lifesciences
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Edwards Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Edwards Lifesciences' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Edwards Lifesciences or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ChairmanMichael Mussallem
Business ConcentrationMedical Devices, Healthcare (View all Sectors)
Edwards Lifesciences (EW) is traded on Mexican Exchange in Mexico and employs 15,700 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 913.09 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Edwards Lifesciences's market, we take the total number of its shares issued and multiply it by Edwards Lifesciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Edwards Lifesciences classifies itself under Healthcare sector and is part of Medical Devices industry. The entity has 618.26 M outstanding shares. Edwards Lifesciences has accumulated about 1.56 B in cash with 1.73 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.51.
Check Edwards Lifesciences Probability Of Bankruptcy
Ownership Allocation
Edwards Lifesciences holds a total of 618.26 Million outstanding shares. The majority of Edwards Lifesciences outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Edwards Lifesciences to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Edwards Lifesciences. Please pay attention to any change in the institutional holdings of Edwards Lifesciences as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Edwards Ownership Details

Edwards Lifesciences Risk Profiles

Although Edwards Lifesciences' alpha and beta are two of the key measurements used to evaluate Edwards Lifesciences' performance over the market, the standard measures of volatility play an important role as well.

Edwards Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Edwards Lifesciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Money Flow Index Now

   

Money Flow Index

Determine momentum by analyzing Money Flow Index and other technical indicators
All  Next Launch Module

Edwards Lifesciences Corporate Management

Elected by the shareholders, the Edwards Lifesciences' board of directors comprises two types of representatives: Edwards Lifesciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Edwards. The board's role is to monitor Edwards Lifesciences' management team and ensure that shareholders' interests are well served. Edwards Lifesciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Edwards Lifesciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
Paul LaVioletteDirectorProfile
Larry WoodCorporate Vice President - Transcatheter Aortic Valve ReplacementProfile
Nicholas ValerianiIndependent DirectorProfile
Heisz StoneIndependent DirectorProfile
Mark WilterdingVP RelationsProfile
Catherine SzymanCorporate Vice President - Critical CareProfile

Additional Tools for Edwards Stock Analysis

When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.